Vanguard Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $503M | Sell |
|
|||||
|
2025
Q2 | $446M | Sell |
|
|||||
|
2025
Q1 | $466M | Sell |
|
|||||
|
2024
Q4 | $631M | Buy |
|
|||||
|
2024
Q3 | $638M | Sell |
|
|||||
|
2024
Q2 | $649M | Sell |
|
|||||
|
2024
Q1 | $837M | Buy |
|
|||||
|
2023
Q4 | $772M | Buy |
|
|||||
|
2023
Q3 | $840M | Sell |
|
|||||
|
2023
Q2 | $908M | Sell |
|
|||||
|
2023
Q1 | $1.15B | Buy |
|
|||||
|
2022
Q4 | $1.01B | Buy |
|
|||||
|
2022
Q3 | $981M | Buy |
|
|||||
|
2022
Q2 | $1.16B | Buy |
|
|||||
|
2022
Q1 | $1.31B | Buy |
|
|||||
|
2021
Q4 | $1.73B | Buy |
|
|||||
|
2021
Q3 | $1.69B | Sell |
|
|||||
|
2021
Q2 | $1.47B | Sell |
|
|||||
|
2021
Q1 | $1.31B | Buy |
|
|||||
|
2020
Q4 | $1.32B | Buy |
|
|||||
|
2020
Q3 | $1.16B | Sell |
|
|||||
|
2020
Q2 | $1.04B | Buy |
|
|||||
|
2020
Q1 | $706M | Buy |
|
|||||
|
2019
Q4 | $732M | Buy |
|
|||||
|
2019
Q3 | $640M | Buy |
|
|||||
|
2019
Q2 | $595M | Sell |
|
|||||
|
2019
Q1 | $585M | Buy |
|
|||||
|
2018
Q4 | $438M | Buy |
|
|||||
|
2018
Q3 | $574M | Buy |
|
|||||
|
2018
Q2 | $519M | Buy |
|
|||||
|
2018
Q1 | $439M | Buy |
|
|||||
|
2017
Q4 | $411M | Buy |
|
|||||
|
2017
Q3 | $376M | Buy |
|
|||||
|
2017
Q2 | $380M | Buy |
|
|||||
|
2017
Q1 | $334M | Buy |
|
|||||
|
2016
Q4 | $294M | Buy |
|
|||||
|
2016
Q3 | $254M | Buy |
|
|||||
|
2016
Q2 | $214M | Buy |
|
|||||
|
2016
Q1 | $196M | Buy |
|
|||||
|
2015
Q4 | $192M | Buy |
|
|||||
|
2015
Q3 | $181M | Buy |
|
|||||
|
2015
Q2 | $202M | Buy |
|
|||||
|
2015
Q1 | $175M | Buy |
|
|||||
|
2014
Q4 | $146M | Buy |
|
|||||
|
2014
Q3 | $135M | Buy |
|
|||||
|
2014
Q2 | $140M | Buy |
|
|||||
|
2014
Q1 | $147M | Buy |
|
|||||
|
2013
Q4 | $135M | Buy |
|
|||||
|
2013
Q3 | $123M | Buy |
|
|||||
|
2013
Q2 | $114M | Buy |
|